Results 201 to 210 of about 62,694 (307)

University students' interest in intervention research participation is associated with gender, age and symptoms of depression, general and social anxiety, panic disorder and self-harm. [PDF]

BMC Res Notes
Irving ET, Stikvoort B, Andersson C, Berman AH.   +3 more
europepmc   +1 more source

Psychiatric History and Postpartum Depression: The Mediating Role of Obstetric Complications

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Psychiatric history is the strongest risk factor for postpartum depression (PPD). Obstetric complications, more prevalent among women with a psychiatric history, are also independent risk factors. However, the mechanisms linking these factors to PPD remain unclear.
Mette‐Marie Zacher Kjeldsen, Katrine Holde, Line Bager, Veerle Bergink, Emely Ek Blæhr, Janne Tidselbak Larsen, Kathrine Bang Madsen, Merete Lund Mægbæk, Liselotte Vogdrup Petersen, Trine Munk‐Olsen   +9 more
wiley   +1 more source

The Effect of Cognitive Behavioral Therapy-Based Intervention Program on Psychological Well-Being and Coping with Stress in Persons With Panic Disorder: Quasi-Experimental Design With Two-Site Comparison. [PDF]

Brain Behav
Yildirim Üşenmez T, Kavak Budak F.
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Gut Microbiota Alterations in Patients with Panic Disorder: A Case-Control Study. [PDF]

Nutrients
Grąźlewski T, Kucharska-Mazur J, Samochowiec J, Reginia A, Liśkiewicz P, Michalczyk A, Misiak B, Kaczmarczyk M, Stachowska E.   +8 more
europepmc   +1 more source

Context, mechanisms and outcomes of a social enterprise model of residential rehabilitation for problem substance use: A realist‐informed process evaluation

Addiction, EarlyView.
Abstract Background and aims This study evaluated a three‐year residential rehabilitation programme, which aimed to support recovery from problem substance use via peer support and social enterprise activities. The aims were to clarify programme mechanisms and identify contextual factors associated with variation in outcomes.
Martin Anderson, Lucy Pickering, Mark McCann   +2 more
wiley   +1 more source

Internet-Based Acceptance and Commitment Therapy With Interoceptive Exposure for Panic Disorder: A Randomized Controlled Trial and Working Alliance Analysis. [PDF]

Scand J Psychol
Bäckman L, Weineland S, Vernmark K, Radvogin E, Bjälkebring P, Enbuske E, Hermansson I, Johansson N, Petersen N, Hursti T.   +9 more
europepmc   +1 more source

Improving access to direct acting antivirals via a multimodal integrated care program in an addiction medicine clinic

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Injection drug use is a driver of hepatitis C virus (HCV) transmission, thus integrating HCV care into addiction care is likely necessary for HCV elimination. Here we describe how we integrated HCV care into our addiction medicine (AM) clinic and evaluate its effect on HCV treatment.
Arya Zandvakili, Joseph Rattenni, James Burton, Lakshmi Guduguntla, Marcus Osman, Sayeh Sabbagh, Stephan Arndt, Ben Miskle, Quanhathai Kaewpoowat, Michael Ohl, Andrea Weber, Alison Lynch   +11 more
wiley   +1 more source

The effects of 5-HT on vascular endothelial dysfunction in patients with panic disorder. [PDF]

Front Cardiovasc Med
Feng Y, Li X, Li Z, He X, Tang Y, Tian W.   +5 more
europepmc   +1 more source